Does SECUKINUMAB Cause Affect lability? 176 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 176 reports of Affect lability have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.1% of all adverse event reports for SECUKINUMAB.
176
Reports of Affect lability with SECUKINUMAB
0.1%
of all SECUKINUMAB reports
0
Deaths
146
Hospitalizations
How Dangerous Is Affect lability From SECUKINUMAB?
Of the 176 reports, 146 (83.0%) required hospitalization, and 155 (88.1%) were considered life-threatening.
Is Affect lability Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 176 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Affect lability?
DULOXETINE (2,510)
METFORMIN (291)
AMLODIPINE (274)
METHOTREXATE (266)
ATORVASTATIN (259)
IRBESARTAN (257)
LEVOTHYROXINE (251)
SITAGLIPTIN (244)
ESOMEPRAZOLE (234)
ASPIRIN (224)
Which SECUKINUMAB Alternatives Have Lower Affect lability Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG